Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Reynolds

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Cancer Letters|March 12, 2004
Ceramide synthesis and metabolism as a target for cancer therapyC Patrick Reynolds, Barry J Maurer, Richard N Kolesnick
Analytical Chemistry|June 29, 2017
Microfluidic Separation of Lymphoblasts for the Isolation of Acute Lymphoblastic Leukemia Using the Human Transferrin Receptor as a Capture TargetWenjie Li, Ye Zhang, C Patrick Reynolds, et al.
Methods in Molecular Medicine|May 20, 2005
In vitro testing of chemosensitivity in physiological hypoxiaRita Grigoryan, Nino Keshelava, Clarke Anderson, et al.
Cancer Research|April 3, 2003
Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamineBo Yang, Nino Keshelava, Clarke P Anderson, et al.
Molecular Cancer Therapeutics|March 17, 2007
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinationsTomas Frgala, Ondrej Kalous, Robert T Proffitt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 21, 2004
Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissuesJitka Vratilova, Tomas Frgala, Barry J Maurer, et al.
Current Drug Targets|June 23, 2007
Assessing combinations of cytotoxic agents using leukemia cell linesC Patrick Reynolds, Min H Kang, Nino Keshelava, et al.
Methods in Molecular Medicine|May 20, 2005
DIMSCAN: a microcomputer fluorescence-based cytotoxicity assay for preclinical testing of combination chemotherapyNino Keshelava, Tomás Frgala, Jirí Krejsa, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 22, 2017
Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectivesJason P Cooper, C Patrick Reynolds, Hwangeui Cho, et al.
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Cancer Letters|March 12, 2004
Ceramide synthesis and metabolism as a target for cancer therapyC Patrick Reynolds, Barry J Maurer, Richard N Kolesnick
Analytical Chemistry|June 29, 2017
Microfluidic Separation of Lymphoblasts for the Isolation of Acute Lymphoblastic Leukemia Using the Human Transferrin Receptor as a Capture TargetWenjie Li, Ye Zhang, C Patrick Reynolds, et al.
Methods in Molecular Medicine|May 20, 2005
In vitro testing of chemosensitivity in physiological hypoxiaRita Grigoryan, Nino Keshelava, Clarke Anderson, et al.
Cancer Research|April 3, 2003
Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamineBo Yang, Nino Keshelava, Clarke P Anderson, et al.
Molecular Cancer Therapeutics|March 17, 2007
A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinationsTomas Frgala, Ondrej Kalous, Robert T Proffitt, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 21, 2004
Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissuesJitka Vratilova, Tomas Frgala, Barry J Maurer, et al.
Current Drug Targets|June 23, 2007
Assessing combinations of cytotoxic agents using leukemia cell linesC Patrick Reynolds, Min H Kang, Nino Keshelava, et al.
Methods in Molecular Medicine|May 20, 2005
DIMSCAN: a microcomputer fluorescence-based cytotoxicity assay for preclinical testing of combination chemotherapyNino Keshelava, Tomás Frgala, Jirí Krejsa, et al.
Experimental Biology and Medicine (Maywood, N.J.)|April 22, 2017
Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectivesJason P Cooper, C Patrick Reynolds, Hwangeui Cho, et al.
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Pageof 22